In summary, although GSDMD expression was associated with survival and a decreased M2-type macrophage signature in patients with breast cancer, we did not observe a major impact of GSDMD deficiency in two different mouse cancer models, of which one is known to be IL-1β-dependent. This evidence concerns the gene GSDMD and breast cancer.